GENE ONLINE|News &
Opinion
Blog

Liver
Astellas Ditches Gene Therapies, with Losses Exceeding $390 Million
2022-04-25
Homology Medicines Joins Biomarin in Gene Therapy Clinical Hold
2022-02-22
GSK’s Benlysta Bags Approval for Lupus Nephritis Treatment in China
2022-02-14
Novartis Teams Up with Alnylam to Explore Targeted Liver Therapies
2022-01-07
Korro Bio Raises $116 Million for RNA Editing Program
2022-01-06
Gannex Pharma Announces New Dual Targeting Drug for NASH
2022-01-05
Following Two Years of Promising RNAi Collab, Novo Nordisk Decides to Acquire Dicerna for $3.3 Billion
2021-11-18
R&D
NASH Drug Candidate, ASC42 Receives Fast Track Designation
2020-12-18
December 5, 2012: Scientists Discovered Over 3,000 Epigenetic Switches Control Daily Liver Cycles
2017-12-04
LATEST
Big Pharma’s Next Move: BMS, Merck, Amgen Eye M&A to Tackle Patent Expirations
2024-11-14
Taiwan and Australia Bridge Biotech Frontiers and Strengthen Ties at AusBiotech 2024
2024-11-14
Google DeepMind Open-Sources AlphaFold 3: A Game-Changer for Drug Discovery and Biotech
2024-11-12
Hiroaki Ueno: Leading Japan’s Pharma Revolution with Innovation and Global Strategy
2024-11-12
Japan’s Bio-Economy Push: A Future Driven by Innovation and Global Collaboration
2024-11-12
Opening the Door to ‘Designer Babies’? South Africa’s Genome Editing Guidelines Spark Global Debate
2024-11-08
Infinitopes to Showcase Breakthroughs on Cancer Vaccine Development at SITC 2024: Insight into a double-blind, Phase I/IIa clinical trial
2024-11-08
EVENT
2024-12-05
8th Healthcare Expo Taiwan
Taipei, Taiwan
Scroll to Top